NanoDimension is the famous VC, which was founded in 2002. The fund was located in North America if to be more exact in Cayman Islands. The main department of described VC is located in the Grand Cayman.
We can highlight the next thriving fund investment areas, such as Biotechnology, Electronics. Besides, a startup needs to be aged 2-3 years to get the investment from the fund. The fund has no exact preference in some founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low. For fund there is no match between the location of its establishment and the land of its numerous investments - United States. Among the various public portfolio startups of the fund, we may underline ARMO BioSciences, View, Icosavax
The top amount of exits for fund were in 2018. Comparing to the other companies, this NanoDimension performs on 15 percentage points less the average number of lead investments. The usual things for fund are deals in the range of 10 - 50 millions dollars. The top activity for fund was in 2016. Despite it in 2019 the fund had an activity. Considering the real fund results, this VC is 17 percentage points more often commits exit comparing to other organizations. The fund is constantly included in 2-6 investment rounds annually.
The current fund was established by Aymeric Sallin. The overall number of key employees were 5.
The typical case for the fund is to invest in rounds with 5-6 participants. Despite the NanoDimension, startups are often financed by Flagship Pioneering, Polaris Partners, Paladin Capital Group. The meaningful sponsors for the fund in investment in the same round are Polaris Partners, Paladin Capital Group, Foresite Capital. In the next rounds fund is usually obtained by Flagship Pioneering, RUSNANO, Paladin Capital Group.
Related Funds
Funds with similar focus
| Fund Name | Location |
| Banyan Mezzanine Funds | Florida, Miami, United States |
| BCF Ventures | Canada, Montréal, Quebec |
| Intercement | - |
| JHS Ventures | - |
| Jubilee Capital Management | Central, Central Region, Singapore |
| Keyuexin Investment | Beijing, Beijing, China |
| Launch Code Capital | - |
| Lennar Corporation | Florida, Miami, United States |
| SPSS | Chicago, Illinois, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Icosavax | $100M | 07 Apr 2021 | Seattle, Washington, United States | ||
Arctos Medical | $8M | 18 Dec 2019 | Bern, Switzerland | ||
Icosavax | $51M | 03 Oct 2019 | Seattle, Washington, United States | ||
Amphivena Therapeutics | $62M | 24 Sep 2019 | South San Francisco, California, United States | ||
Inscripta | $20M | 04 Apr 2019 | Boulder, Colorado, United States | ||
Inscripta | $30M | 19 Dec 2018 | Boulder, Colorado, United States | ||
SQZ Biotech | $72M | 08 Aug 2018 | Massachusetts, United States | ||
| $3M | 10 Jul 2018 | San Francisco, California, United States | |||
Inscripta | $55M | 28 Feb 2018 | Boulder, Colorado, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Icosavax | $100M | 07 Apr 2021 | Seattle, Washington, United States | ||
Arctos Medical | $8M | 18 Dec 2019 | Bern, Switzerland | ||
Icosavax | $51M | 03 Oct 2019 | Seattle, Washington, United States | ||
Amphivena Therapeutics | $62M | 24 Sep 2019 | South San Francisco, California, United States | ||
Inscripta | $20M | 04 Apr 2019 | Boulder, Colorado, United States | ||
Inscripta | $30M | 19 Dec 2018 | Boulder, Colorado, United States | ||
SQZ Biotech | $72M | 08 Aug 2018 | Massachusetts, United States | ||
| $3M | 10 Jul 2018 | San Francisco, California, United States | |||
Inscripta | $55M | 28 Feb 2018 | Boulder, Colorado, United States |
